The next important event is The American Society for Clinical Oncology annual meeting. In 2016, this international conference, with a large participation from different countries, revealed many new data from numerous clinical trials, which will change the medical practice. Attendees claimed CME credits, downloaded a Certificate of Attendance, and provided feedback during the meeting.
Another important conference in which many oncologists from Romania participated in 2016 was the ESMO annual Congress. Across disciplines and across cultures, The European Society for Medical Oncology (ESMO) bridges the gap between researchers, clinicians and patients, and unites all stakeholders focused on finding the most effective cancer treatment solutions available today.
Because lung cancer remains the main cause of mortality from cancer, I want to mention the Congress of International Association for the Study of Lung Cancer (IASLC), which was held in Vienna, in December 2016. Medical doctors, scientists, nurses, health professionals, government officials, partners from the industry, health advocacy groups and patients came together and obtained exchange information on both state-of-the-art and advances in the management of lung cancer and other thoracic malignancies, considering both global and regional aspects.
Last but not least, I must mention the National Conference of Romanian National Society for Medical Oncology (SNOMR) - our association for medical oncology -, which reached new performance regarding the participation of international speakers and of Romanian medical oncologists. This conference was endorsed in 2016 by SIOG (International Society for Geriatric Oncology). Another important thing that I want to report is that, as a consequence of my dialog with ESMO, it was decided that our society (SNOMR) has the right to propose an ESMO National representative for 2017-2018.
In the end of this editorial, I must mention the success of our journal, Oncolog-Hematolog.ro, and of Versa Media, to be accepted in 2016 in an international database. The journal is under the auspices of SNOMR and The Institute of Oncology Bucharest.
Alexandru C. GRIGORESCU, MD, PhD